Efficacy of Pimobendan in the Prevention of Congestive Heart Failure or Sudden Death in Doberman Pinschers with Preclinical Dilated Cardiomyopathy (The PROTECT Study)

BACKGROUND: The benefit of pimobendan in delaying the progression of preclinical dilated cardiomyopathy (DCM) in Dobermans is not reported. HYPOTHESIS: That chronic oral administration of pimobendan to Dobermans with preclinical DCM will delay the onset of CHF or sudden death and improve survival. A...

Descripción completa

Detalles Bibliográficos
Autores principales: Summerfield, NJ, Boswood, A, O'Grady, MR, Gordon, SG, Dukes-McEwan, J, Oyama, MA, Smith, S, Patteson, M, French, AT, Culshaw, GJ, Braz-Ruivo, L, Estrada, A, O'Sullivan, ML, Loureiro, J, Willis, R, Watson, P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2012
Materias:
Standard Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546380/
https://www.ncbi.nlm.nih.gov/pubmed/23078651
http://dx.doi.org/10.1111/j.1939-1676.2012.01026.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546380/
https://www.ncbi.nlm.nih.gov/pubmed/23078651
http://dx.doi.org/10.1111/j.1939-1676.2012.01026.x

Ejemplares similares